Keywords: cms, cover, off-label, cancer, drug, use, lehman

US CMS cover for off-label cancer drug use

Article | 15 November 2004

Print This

Lehman Healthcare analysts have discussed the pre-election news that the US Centers for Medicare & Medicaid Services plans to provide, for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in